Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrate dose comparison in regional citrate anticoagulation during hemodialysis
ACTRN12613001340729Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of trisodium citrate in chronic kidney disease (CKD) (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Increase in thrombin-antithrombin complex. Started Jan 2018; status: completed.
02
Drugs
trisodium citrate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12613001340729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001340729.